Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
190.3 EUR | +2.62% | +6.13% | -20.54% |
Jun. 03 | SARTORIUS STEDIM BIOTECH : EPS cut (2023: -13.7%, 2024: -16.4%) | |
May. 16 | Sartorius sinks again towards year low | DP |
Sales 2024 * | 2.94B 3.16B | Sales 2025 * | 3.33B 3.58B | Capitalization | 18.05B 19.43B |
---|---|---|---|---|---|
Net income 2024 * | 335M 361M | Net income 2025 * | 451M 486M | EV / Sales 2024 * | 6.92 x |
Net Debt 2024 * | 2.27B 2.44B | Net Debt 2025 * | 2.16B 2.33B | EV / Sales 2025 * | 6.07 x |
P/E ratio 2024 * |
52.2
x | P/E ratio 2025 * |
37.5
x | Employees | 10,493 |
Yield 2024 * |
0.4% | Yield 2025 * |
0.59% | Free-Float | 31.97% |
Latest transcript on Sartorius Stedim Biotech
1 day | +0.43% | ||
1 week | +2.15% | ||
Current month | +1.53% | ||
1 month | -9.84% | ||
3 months | -31.29% | ||
6 months | -9.45% | ||
Current year | -22.57% |
Managers | Title | Age | Since |
---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 48 | 19-03-25 |
Chairman | 59 | 07-06-28 | |
Chief Tech/Sci/R&D Officer | 59 | 09-04-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Henri Riey
BRD | Director/Board Member | 62 | 07-06-28 |
Chairman | 59 | 07-06-28 | |
Susan Dexter
BRD | Director/Board Member | 67 | 15-04-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.42% | 21 M€ | +8.03% | - | |
0.35% | 5 M€ | +4.56% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-11 | 190.3 | +2.62% | 8 961 |
24-06-10 | 185.4 | +0.43% | 68,540 |
24-06-07 | 184.6 | -0.91% | 52,754 |
24-06-06 | 186.4 | +1.06% | 58,644 |
24-06-05 | 184.4 | +2.84% | 56,218 |
Real-time Euronext Paris, June 10, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.57% | 19.39B | |
-2.34% | 187B | |
+0.92% | 109B | |
-1.77% | 69.22B | |
+14.21% | 46.19B | |
-6.06% | 46.36B | |
+8.48% | 42.44B | |
+19.03% | 30.84B | |
+19.69% | 25.73B | |
-7.25% | 23.22B |
- Stock Market
- Equities
- DIM Stock